Systemic inflammation during severe infections, as well as exposure to pro-inflammatory cytokines like TNF and IFNγ, is closely associated with a reduction in insulin’s intracellular effects, a condition referred to as insulin resistance [1,2,3]. This evidence concerns the gene INS and Insulin resistance.